The Pictorial Screening Memory Test (P-MIS) for Adults with Moderate Intellectual Disability and Alzheimer's Disease.


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
30 08 2022
Historique:
received: 13 07 2022
revised: 19 08 2022
accepted: 20 08 2022
entrez: 9 9 2022
pubmed: 10 9 2022
medline: 14 9 2022
Statut: epublish

Résumé

In this study, we examined normative data and diagnostic accuracy of a pictorial screening test to detect memory impairment for mild cognitive impairment (MCI) and Alzheimer's disease (AD) in Spanish-speaking adults with intellectual disability (ID). A total of 94 volunteers with ID (60 controls, 17 MCI, and 17 AD), were evaluated by neuropsychological tests including the PMIS-ID in a cross-sectional validation study. Discriminative validity between the MCI, AD, and control group was analyzed by the area under the ROC curve. A cut-off score of 4.5 on the immediate recall trial had a sensitivity of 69% and a specificity of 80% to detect memory impairment (AUC = 0.685; 95% CI = 0.506-0.863) in the AD group. The PMIS-ID is a useful screening test to rule out a diagnosis of memory decline in people with moderate level of ID and AD, and it shows good psychometric properties.

Identifiants

pubmed: 36078496
pii: ijerph191710780
doi: 10.3390/ijerph191710780
pmc: PMC9518372
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Int J Geriatr Psychiatry. 2020 Jun;35(6):650-661
pubmed: 32100307
J Appl Res Intellect Disabil. 2018 Sep;31(5):725-742
pubmed: 29424088
Alzheimers Dement (Amst). 2015 Mar 1;1(1):94-100
pubmed: 25870860
Alzheimers Dement (Amst). 2020 Jun 28;12(1):e12047
pubmed: 32613076
Trends Cogn Sci. 2013 Oct;17(10):502-9
pubmed: 24018144
Neurologia. 2005 Oct;20(8):402-11
pubmed: 16217689
Brain Behav. 2017 Feb 09;7(3):e00645
pubmed: 28293480
Am J Intellect Dev Disabil. 2015 Nov;120(6):481-9
pubmed: 26505869
Alzheimers Dement. 2019 Feb;15(2):245-257
pubmed: 30503169
J Am Geriatr Soc. 2012 Nov;60(11):2116-20
pubmed: 23039180
Brain Connect. 2021 Nov;11(9):725-733
pubmed: 33858203
Neurology. 1999 Jan 15;52(2):231-8
pubmed: 9932936
Autism Res. 2021 Oct;14(10):2189-2199
pubmed: 34378867
J Appl Res Intellect Disabil. 2017 Sep;30(5):824-829
pubmed: 27494573
Neurologia (Engl Ed). 2022 Apr;37(3):192-198
pubmed: 35465913
Curr Opin Psychiatry. 2014 Mar;27(2):143-8
pubmed: 24406638
Cortex. 2005 Aug;41(4):452-63
pubmed: 16042022
Neuroimage Clin. 2018 Jan 28;18:160-166
pubmed: 29868444
Radiology. 1983 Sep;148(3):839-43
pubmed: 6878708
Dev Med Child Neurol. 2022 Mar;64(3):372-378
pubmed: 34496036
Am J Ment Retard. 2004 Mar;109(2):98-110
pubmed: 15000667
Rev Neurol. 2017 May 16;64(10):433-444
pubmed: 28497439
J Clin Neuropsychol. 1984 Nov;6(4):433-40
pubmed: 6501581
J Alzheimers Dis. 2021;79(4):1397-1407
pubmed: 33459644
J Intellect Disabil Res. 2017 Sep;61(9):843-852
pubmed: 28664561
Rev Neurol. 2005 Jun 1-15;40(11):644-8
pubmed: 15948064
Lancet. 2020 Jun 27;395(10242):1988-1997
pubmed: 32593336
Int J Geriatr Psychiatry. 2020 Apr;35(4):414-422
pubmed: 31894597
J Alzheimers Dis. 2017;57(1):61-70
pubmed: 28222523
J Appl Res Intellect Disabil. 2021 Nov;34(6):1463-1467
pubmed: 33932064
Ann Clin Transl Neurol. 2018 May 20;5(6):741-751
pubmed: 29928657
Res Dev Disabil. 1990;11(2):177-98
pubmed: 2142796
J Alzheimers Dis. 2016 Mar 5;52(1):283-93
pubmed: 27060959
Neurobiol Aging. 2019 Dec;84:70-79
pubmed: 31518951
Res Dev Disabil. 2010 Nov-Dec;31(6):1475-80
pubmed: 20630702
Res Dev Disabil. 2006 May-Jun;27(3):299-308
pubmed: 16054334
Brain Sci. 2020 Nov 12;10(11):
pubmed: 33198271
Arch Clin Neuropsychol. 2016 Mar;31(2):165-75
pubmed: 26758367
Alzheimer Dis Assoc Disord. 2011 Apr-Jun;25(2):122-7
pubmed: 20921876
PLoS One. 2012;7(5):e37527
pubmed: 22662166
J Neurophysiol. 2002 Aug;88(2):982-90
pubmed: 12163547
J Intellect Disabil Res. 2002 Mar;46(Pt 3):198-208
pubmed: 11896805
J Intellect Disabil Res. 2007 May;51(Pt 5):377-86
pubmed: 17391254
J Appl Res Intellect Disabil. 2022 Mar;35(2):495-505
pubmed: 34693611
Child Neuropsychol. 2000 Sep;6(3):235-8
pubmed: 11419452
Dev Disabil Res Rev. 2013;18(1):31-42
pubmed: 23949827
Dev Disabil Res Rev. 2013;18(1):6-16
pubmed: 23949824
J Alzheimers Dis. 2018;61(2):589-600
pubmed: 29226861
Aging (Albany NY). 2021 Jan 26;13(2):1773-1816
pubmed: 33497355
Rev Neurol. 2013 Oct 16;57(8):337-46
pubmed: 24081888
J Intellect Disabil. 2006 Dec;10(4):357-64
pubmed: 17105742
J Intellect Disabil Res. 1996 Aug;40 ( Pt 4):369-73
pubmed: 8884592
Cortex. 1980 Aug;16(2):255-71
pubmed: 7471766

Auteurs

Emili Rodríguez-Hidalgo (E)

Specialized Service in Mental Health and Intellectual Disability, Institute of Health Assistance, Parc Hospitalari Martí i Julià, Catalonia, 17190 Girona, Spain.

Javier García-Alba (J)

Research and Psychology in Education Department, Complutense University of Madrid, 28040 Madrid, Spain.

Maria Buxó (M)

Neurodevelopmental Group [Girona Biomedical Research Institute]-IDIBGI, Institute of Health Assistance (IAS), Parc Hospitalari Martí i Julià, Catalonia, 17190 Girona, Spain.

Ramon Novell (R)

Specialized Service in Mental Health and Intellectual Disability, Institute of Health Assistance, Parc Hospitalari Martí i Julià, Catalonia, 17190 Girona, Spain.
Neurodevelopmental Group [Girona Biomedical Research Institute]-IDIBGI, Institute of Health Assistance (IAS), Parc Hospitalari Martí i Julià, Catalonia, 17190 Girona, Spain.

Susana Esteba-Castillo (S)

Specialized Service in Mental Health and Intellectual Disability, Institute of Health Assistance, Parc Hospitalari Martí i Julià, Catalonia, 17190 Girona, Spain.
Neurodevelopmental Group [Girona Biomedical Research Institute]-IDIBGI, Institute of Health Assistance (IAS), Parc Hospitalari Martí i Julià, Catalonia, 17190 Girona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH